These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 2139436

  • 1. In-vitro studies with ramoplanin (MDL 62,198): a novel lipoglycopeptide antimicrobial.
    O'Hare MD, Ghosh G, Felmingham D, Grüneberg RN.
    J Antimicrob Chemother; 1990 Feb; 25(2):217-20. PubMed ID: 2139436
    [Abstract] [Full Text] [Related]

  • 2. The in vitro activity of ramoplanin (A-16686/MDL 62,198), vancomycin and teicoplanin against methicillin-susceptible and methicillin-resistant Staphylococcus spp.
    O'Hare MD, Felmingham D, Grüneberg RN.
    Drugs Exp Clin Res; 1988 Feb; 14(10):617-9. PubMed ID: 2977587
    [Abstract] [Full Text] [Related]

  • 3. In-vitro activity of ramoplanin (a novel lipoglycopeptide), vancomycin, and teicoplanin against gram-positive clinical isolates from cancer patients.
    Rolston KV, Dholakia N, Ho DH, LeBlanc B, Dvorak T, Streeter H.
    J Antimicrob Chemother; 1996 Aug; 38(2):265-9. PubMed ID: 8877541
    [Abstract] [Full Text] [Related]

  • 4. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
    Bartoloni A, Colao MG, Orsi A, Dei R, Giganti E, Parenti F.
    J Antimicrob Chemother; 1990 Nov; 26(5):627-33. PubMed ID: 1688341
    [Abstract] [Full Text] [Related]

  • 5. In vitro evaluation of ramoplanin (A16686 or MDL62198). A new depsipeptide complex for potential topical use.
    Jones RN, Barry AL.
    Diagn Microbiol Infect Dis; 1989 Nov; 12(3):279-82. PubMed ID: 2507218
    [Abstract] [Full Text] [Related]

  • 6. Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci.
    Shonekan D, Mildvan D, Handwerger S.
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1570-2. PubMed ID: 1324649
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of teicoplanin, vancomycin, A16686, clindamycin, erythromycin and fusidic acid against anaerobic bacteria.
    Hassan H, O'Hare MD, Felmingham D.
    Singapore Med J; 1990 Feb; 31(1):56-8. PubMed ID: 2139737
    [Abstract] [Full Text] [Related]

  • 8. In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria.
    Citron DM, Merriam CV, Tyrrell KL, Warren YA, Fernandez H, Goldstein EJ.
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2334-8. PubMed ID: 12821492
    [Abstract] [Full Text] [Related]

  • 9. Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus.
    Maple PA, Hamilton-Miller JM, Brumfitt W.
    J Antimicrob Chemother; 1989 Apr; 23(4):517-25. PubMed ID: 2526111
    [Abstract] [Full Text] [Related]

  • 10. In vitro bactericidal activity of the glycopeptide compounds vancomycin, teicoplanin and ramoplanin (A-16686/MDL 62,198).
    O'Hare MD, Felmingham D, Grüneberg RN.
    J Chemother; 1989 Jul; 1(4 Suppl):210-1. PubMed ID: 16312373
    [No Abstract] [Full Text] [Related]

  • 11. In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of gram-positive cocci.
    Lawrence T, Rotstein C, Beam TR, Gorzynski EA, Amsterdam D.
    Antimicrob Agents Chemother; 1993 Apr; 37(4):896-900. PubMed ID: 8494388
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of vancomycin and teicoplanin against anaerobic bacteria.
    Robbins MJ, Marais R, Felmingham D, Ridgway GL, Grüneberg RN.
    Drugs Exp Clin Res; 1987 Apr; 13(9):551-4. PubMed ID: 2962846
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of ramoplanin against vancomycin-resistant gram-positive organisms.
    Collins LA, Eliopoulos GM, Wennersten CB, Ferraro MJ, Moellering RC.
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1364-6. PubMed ID: 8328787
    [Abstract] [Full Text] [Related]

  • 14. In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates of Clostridium difficile.
    Biavasco F, Manso E, Varaldo PE.
    Antimicrob Agents Chemother; 1991 Jan; 35(1):195-7. PubMed ID: 1826593
    [Abstract] [Full Text] [Related]

  • 15. In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873.
    Biavasco F, Lupidi R, Varaldo PE.
    Antimicrob Agents Chemother; 1992 Feb; 36(2):331-8. PubMed ID: 1534977
    [Abstract] [Full Text] [Related]

  • 16. Ramoplanin versus methicillin-resistant Staphylococcus aureus: in vitro experience.
    Brumfitt W, Maple PA, Hamilton-Miller JM.
    Drugs Exp Clin Res; 1990 Feb; 16(8):377-83. PubMed ID: 2097143
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres.
    Gales AC, Sader HS, Jones RN.
    Clin Microbiol Infect; 2005 Feb; 11(2):95-100. PubMed ID: 15679482
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of teicoplanin and vancomycin against gram-positive bacteria from human clinical and veterinary sources.
    Jensen KT, Schønheyder H, Pers C, Thomsen VF.
    APMIS; 1992 Jun; 100(6):543-52. PubMed ID: 1535201
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of ramoplanin on staphylococci.
    Francis J, Webster H, Newsom SW.
    Drugs Exp Clin Res; 1990 Jun; 16(9):457-60. PubMed ID: 2100247
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of decaplanin (M86-1410), a new glycopeptide antibiotic.
    Sanchez ML, Wenzel RP, Jones RN.
    Antimicrob Agents Chemother; 1992 Apr; 36(4):873-5. PubMed ID: 1386973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.